Absorption and Elimination of Oat Avenanthramides in Humans after Acute Consumption of Oat Cookies

Table 3

Pharmacokinetic properties of AVAs.

	Cmax (ng/ml)		Tmax (h)		T1/2 (h)
	H-AVA	L-AVA	H-AVA	L-AVA	H-AVA	L-AVA
AVA-A	8.39 ± 4.2^c	1.98 ± 1.3	2.50 ± 1.2	1.80 ± 1.3	2.16 ± 0.6^b	2.44 ± 0.8
AVA-B	8.44 ± 2.3^c	2.43 ± 1.1	2.04 ± 0.9	1.50 ± 1.5	4.23 ± 0.8^ac	4.60 ± 2.7
AVA-C	4.26 ± 2.0^ab	1.33 ± 0.7	2.29 ± 1.0	1.32 ± 1.0	2.71 ± 1.2^b	2.87 ± 1.4

versus H-AVA; ^a versus AVA-A within H-AVA or L-AVA group; ^b versus AVA-B within H-AVA or L-AVA group; ^c versus AVA-C within H-AVA or L-AVA group.